Evidence-based policy recommendations on cancer screening and prevention

Schatzkin A. Intermediate markers in cancer research: theoretical and practical issues in the use of surrogate endpoints. In: Franco EL, Rohan TE, editors. Cancer precursors: epidemiology, detection, and prevention. New York: Springer; 2002. p. 46–59. Kelloff GJ, Sigman C. Chemoprevention. In: Franco EL, Rohan TE, editors. Cancer precursors: epidemiology, detection, and prevention. New York: Springer; 2002. p. 374–88. Screening for cancer PDQ® screening/detection—health professionals. http://cancer.gov/templates/list.aspx?viewid=33b41db3-9099-4705-a77d-590a60637451. Accessed 10 May 2002. Kramer BS. NCI state-of-the-art statements on cancer screening. In: Greenwald P, Kramer BS, Weed DL, editors. Cancer prevention and control. New York: Marcel Dekker; 1995. p. 721. Baines, 1997, Mammography versus clinical examination of the breasts, J Natl Cancer Inst Monogr, 22, 125, 10.1093/jncimono/1997.22.125 Olsen, 2001, Cochrane review on screening for breast cancer with mammography, Lancet, 358, 1340, 10.1016/S0140-6736(01)06449-2 Miettinen, 2002, Mammographic screening: no reliable supporting evidence?, Lancet, 359, 404, 10.1016/S0140-6736(02)07592-X La Vecchia, 1984, Pap smear and the risk of cervical neoplasia: quantitative estimates from a case-control study, Lancet, 2, 779, 10.1016/S0140-6736(84)90705-0 Herrero, 1992, Screening for cervical cancer in Latin America: a case-control study, Int J Epidemiol, 21, 1050, 10.1093/ije/21.6.1050 Laara, 1987, Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes, Lancet, 1, 1247, 10.1016/S0140-6736(87)92695-X Benedet, 1992, A comprehensive program for cervical cancer detection and management, Am J Obstet Gynecol, 166, 1254, 10.1016/S0002-9378(11)90618-8 Hardcastle, 1996, Randomised controlled trial of faecal-occult-blood screening for colorectal cancer, Lancet, 348, 1472, 10.1016/S0140-6736(96)03386-7 Kronborg, 1996, Randomised study of screening for colorectal cancer with faecal-occult-blood test, Lancet, 348, 1467, 10.1016/S0140-6736(96)03430-7 Winawer, 1993, Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy, J Natl Cancer Inst, 85, 1311, 10.1093/jnci/85.16.1311 Mandel, 1999, Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood, J Natl Cancer Inst, 91, 434, 10.1093/jnci/91.5.434 Winawer, 1997, Colorectal cancer screening: clinical guidelines and rationale, Gastroenterology, 112, 594, 10.1053/gast.1997.v112.agast970594 Winawer, 1993, The National Polyp Study Workgroup: prevention of colorectal cancer by colonoscopic polypectomy, New Engl J Med, 329, 1977, 10.1056/NEJM199312303292701 Rembacken, 2000, Flat and depressed colonic neoplasms: a prospective study of 1000 colonoscopies in the UK, Lancet, 355, 1211, 10.1016/S0140-6736(00)02086-9 Lieberman, 2000, Use of colonoscopy to screen asymptomatic adults for colorectal cancer: Veterans Affairs Cooperative Study Group 380, New Engl J Med, 343, 162, 10.1056/NEJM200007203430301 Imperiale, 2000, Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings, New Engl J Med, 343, 169, 10.1056/NEJM200007203430302 Prorok, 2000, The prostate, lung, colorectal and ovarian cancer screening trial project team: design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial, Control Clin Trials, 21, 273S, 10.1016/S0197-2456(00)00098-2 Nanda, 2000, Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review, Ann Int Med, 132, 810, 10.7326/0003-4819-132-10-200005160-00009 Cuzick, 2000, A systematic review of the role of human papilloma virus (HPV) testing within a cervical screening programme: summary and conclusions, Br J Cancer, 83, 561, 10.1054/bjoc.2000.1375 Henschke, 1999, Early Lung Cancer Action Project: overall design and findings from baseline screening, Lancet, 354, 99, 10.1016/S0140-6736(99)06093-6 Marcus, 2000, Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up, J Natl Cancer Inst, 92, 1308, 10.1093/jnci/92.16.1308 US Preventive Services Task Force. Guide to Clinical Preventive Services, 2nd ed. Washington, DC: US Department of Health and Human Services; 1996/2002. http://www.ahcpr.gov/clinic/uspstfix.htm. Accessed 10 May 2002. Canadian Task Force on Preventive Health Care. The Canadian Guide to Clinical Preventive Health Care. Canada, Ottawa: Health Canada; 1994. http://www.ctfphc.org. Accessed 10 May 2002. Anonymous. Colorectal cancer screening. Recommendation statement from the Canadian Task Force on Preventive Health Care. Can Med Assoc J 2001;165:206–8. Levine, 2001, Chemoprevention of breast cancer: a joint guideline from the Canadian Task Force on Preventive Health Care and the Canadian Breast Cancer Initiative’s Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer, Can Med Assoc J, 164, 1681 Ringash, 2001, Preventive health care, 2001 update: screening mammography among women aged 40–49 years at average risk of breast cancer, Can Med Assoc J, 164, 469 Baxter, 2001, The Canadian Task Force on Preventive Health Care: preventive health care, 2001 update: should women be routinely taught breast self-examination to screen for breast cancer?, Can Med Assoc J, 164, 1837 Chalmers I. The Cochrane Collaboration: preparing, maintaining and disseminating systematic reviews of the effects of health care. In: Warren KS, Mosteller F, editors. Doing more good than harm: the evaluation of health care interventions. Ann New York Acad Sci 1993;703:156–63. Abstracts of Cochrane Reviews. The Cochrane Library Issue 4; 2000. http://www.update-software.com/cochrane/cochrane-frame.html. Accessed 10 May 2002. McCrory DC, Matchar DB, Bastian L, et al. Evaluation of Cervical Cytology. Evidence Report/Technology Assessment No. 5. AHCPR Publication No. 99-E010. Agency for Health Care Policy and Research, US Department of Health and Human Services, Rockville, MD, February 1999. Agency for Health Care Policy and Research. Colorectal Cancer Screening. Technical Review 1. AHCPR Publication No. 98-0033. US Department of Health and Human Services, Rockville, MD, May 1998. Noorani HZ, Arratoon C, Hall A. Assessment of techniques for cervical cancer screening. Canadian Coordinating Office for Health Technology Assessment, Ottawa, May 1997. Cuzick, 1999, A systematic review of the role of human papillomavirus testing within a cervical screening programme, Health Technol Assess, 3, 1, 10.3310/hta3140 Payne, 2000, Liquid-based cytology in cervical screening: a rapid and systematic review, Health Technol Assess, 4, 1, 10.3310/hta4180 Hubbard SM, Shields VT, Thurn AL. Information systems in oncology. In: Devita VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology, 5th ed. Philadelphia: Lippincott-Raven; 1997. p. 2983–91. National Cancer Institute. CancerNet PDQ(r) Cancer Information Summaries: Prevention. http://cancernet.nci.nih.gov/pdq/pdq_prevention.shtml. Accessed 10 May 2002. Gail, 1999, Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer, J Natl Cancer Inst, 91, 1829, 10.1093/jnci/91.21.1829 Janne, 2000, Chemoprevention of colorectal cancer, New Engl J Med, 342, 1960, 10.1056/NEJM200006293422606 Pike, 2000, Progestins and menopause: epidemiological studies of risks of endometrial and breast cancer, Steroids, 65, 659, 10.1016/S0039-128X(00)00122-7 The Alpha-Tocopherol. Beta Carotene Cancer Prevention Study Group: the effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. New Engl J Med 1994;330:1029–35. Omenn, 1996, Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease, New Engl J Med, 334, 1150, 10.1056/NEJM199605023341802 IARC Handbook of Cancer Prevention. Carotenoids, vol. 2. Lyon: World Health Organization, International Agency for Cancer Research; 1998. Cochrane Tobacco Addiction Group. Abstracts of Cochrane reviews. The Cochrane Library Issue 2, 2002. http://www.update-software.com/abstracts/g160index.htm. Accessed 10 May 2002. Cochrane Gynaecological Cancer Group. Abstracts of Cochrane Reviews. The Cochrane Library Issue 2, 2002. http://www.update-software.com/abstracts/ab001035.htm. Accessed 10 May 2002. National Institutes of Health Consensus Development Conference Statement: Breast Cancer Screening for Women Ages 40–49, 21–23 January 1997. National Institutes of Health Consensus Development Panel. J Natl Cancer Inst 1997;89:1015–26. Taubes, 1997, NCI reverses one expert panel, sides with another, Science, 276, 27, 10.1126/science.276.5309.27 Anonymous. Breast cross-examination. Can Med Assoc J 2001;165:261. American Cancer Society. ACS cancer detection guidelines—cancer-related check-up. http://www.cancer.org/eprise/main/docroot/PED/content/PED_2_3X_ACS_Cancer_Detection_Guidelines_36. Accessed 10 May 2002.